[1]
Amin, K.M. et al. 2016. Design, synthesis, anticancer evaluation and molecular docking of new V600EBRAF inhibitors derived from pyridopyrazinone. European Journal of Chemistry. 7, 1 (Mar. 2016), 19–29. DOI:https://doi.org/10.5155/eurjchem.7.1.19-29.1346.